Curb costs with all-in-one cardiometabolic care

Most wellness or point solutions focus on a single condition or a narrow approach. 9amHealth is designed to be more holistic. We deliver integrated, multispecialty care across all cardiometabolic conditions—at one transparent price point. Our team of endocrinologists, obesity medicine specialists, pharmacists, dietitians, and certified diabetes care specialists works together to support each member’s long-term health through personalized medication management, lifestyle and nutrition coaching, and behavioral health support.

9amHealth supports the full spectrum of cardiometabolic conditions: Type 2 Diabetes; Prediabetes; Obesity/Weight Management; Hypertension; Dyslipidemia (high cholesterol), with more coming soon.

Yes– but only when clinically appropriate. Unlike other vendors that may default to expensive medications, we follow a step-therapy model: starting with lifestyle interventions and generics before advancing to GLP-1s. For eligible members, GLP-1s are prescribed with built-in engagement requirements (coaching, biometric tracking, ongoing participation), ensuring the right therapy at the right time and reducing waste.

By combining evidence-based medication management with whole-person care, 9amHealth reduces unnecessary GLP-1 spending, improves adherence, and helps members work toward deprescribing when appropriate. The result: optimized formulary compliance, reduced medication waste, and lower long-term costs driven by fewer diabetes and cardiovascular complications.

Our outcomes are proven and measurable: 9.3% average weight reduction in 12 months without GLP-1s, and 17.6% with GLP-1s; A1c reductions of up to 2.8 points in individuals with uncontrolled diabetes; Blood pressure reductions averaging 19.8/12.9 mmHg; NPS of +80, demonstrating high member satisfaction.

Evidence shows that employees with obesity and related conditions — including type 2 diabetes, hypertension, and sleep apnea — drive disproportionate downstream claims costs. Structured GLP-1 programs with behavioral support have demonstrated reductions in cardiovascular events and hospitalizations, translating into measurable long-term savings for self-insured employers.

Employers should evaluate programs on four criteria: clinical eligibility screening to reduce unnecessary prescriptions, integrated virtual care (not just prescription access), outcomes tracking tied to biometric and claims data, and transparent pmpm pricing. Programs that lack clinical oversight tend to have high abandonment rates and poor ROI.

The most effective approach combines clinical eligibility criteria (BMI thresholds, comorbidity requirements), enrollment in a virtual care program, and ongoing engagement tracking. Employers using this model report lower per-member costs compared to open formulary coverage.